U of A uses nanotechnology to develop new test for aggressive prostate cancer

Author: Scott Leitch, Edmonton Journal

The Alberta Prostate Cancer Research initiative claims its new blood test is 40 per cent more accurate at identifying men with aggressive forms of prostate cancer than the common prostate-specific antigen (PSA) blood test, which researchers say often leads to unneeded biopsies.

“We know what we will really want in patients is to detect which patients are going to have metastatic cancer down the road because we need to cure them now,” said Dr. John Lewis, a University of Alberta oncology researcher who helped develop the new test.

Read full article here.